Demonstration Formulary
 
back
4 Central nervous system

PALLIATIVE CARE PHYSICIANS - Guidelines for the use of drugs in symptom control

 

04-10-01 Alcohol dependence

Acamprosate Campral EC®
Formulary

For initiation by specialists in substance misuse


Specialist advice View adult BNF  View SPC online  View childrens BNF
Chlordiazepoxide
Formulary

Adjunct in acute alcohol withdrawal


All settings View adult BNF  View SPC online  View childrens BNF
Diazepam
Formulary

All settings View adult BNF  View SPC online  View childrens BNF
Disulfiram Antabuse®
Formulary

Specialist advice View adult BNF  View SPC online  View childrens BNF
Nalmefene
Restricted

Restricted to Specialist Substance Misuse Services only (as per the local authority public health approved pathways)

Reach Out Recovery (CRI) in Birmingham. Single point of contact 24/7 Tel: 0121 227 5890 Link Reach Out Recovery website

Swanswell in Sandwell Tel: 0121 553 1333 Link to Swanswell website

SIAS in Solihull Tel:0121 301 3600 Link to SIAS website

The Nalmefen for reducung alcohol consumption technology appraisal (TA325) recommends this drug as a possible treatment for people with alcohol dependence who:

  • are still drinking more than 7.5 units per day (men) and more than 5 units per day (women) 2 weeks after an initial assessement and
  • do  not have physical withdrawal symptoms and
  • do not need to either stop drinking straight away or stop drinkling completely

The guidance also recommends that nalmefene should only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption

Link  NICE TA325: Nalmefene for reducing alcohol consumption in people with alcohol dependence

Restricted Drug Specialist only View adult BNF  View SPC online  View childrens BNF
Naltrexone
Formulary

Useful as an adjunct in the treatment of alcohol dependence after a successful withdrawal


Specialist advice View adult BNF  View SPC online  View childrens BNF